Abstract
Thyroid dysfunction during pregnancy may affect the mother as well as the fetus. Before considering the clinical entities occurring during and after pregnancy, it is useful to briefly review thyroid physiology and immunology in relation to pregnancy
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Burrow GN, Fisher DA, and Larsen PR. Maternal and fetal thyroid function. N Eng J Med 1994;331: 1072–1078.
Glinoer, D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997;18:404–433.
Smyth PPA, Hetherton AMT, Smith DF, and Radcliffe M. Maternal iodine status and thyroid volume during pregnancy: correlation with neonatal iodine intake. J Clin Endocrinol Metab 1997;82:2840–2843.
Berghout A, Wiersinga W. Thyroid size and thyroid function during pregnancy: an analysis. Euro J Endocrinol 1998;138:536–542.
Vermiglio F, Lo Presti VP, Scaffidi Argentina G, et al. Maternal hypothyroxinaemia during the first half of gestation in an iodine deficient area with endemic cretinism and related disorders. Clin Endocrinol (Oxf) 1995;42:409–415.
Glinoer D, Lemone M. Goiter and pregnancy: a new insight into an old problem. Thyroid 1992;2:65–70.
Glinoer D, De Nayer P, Delange F, et al. A randomised trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. J Clin Endocrinol Metab 1995;80:258–269.
Brent GA. Maternal thyroid function: interpretation of thyroid function tests in preganancy. Clin Obstet Gynecol 1997;40, 3–15.
Yoshimura M, Nishikawa M, Yoshikawa N, et al. Mechanism of thyroid stimulation by human chorionic gonadotropin in sera of normal pregnant women. Acta Endocrinol (Copenh) 1991;124:173–178.
Hoermann R, Poertl S, Liss I, Amir SM, Mann K. Variation in the thyrotropic activity of human chorionicgonadotropin in Chinese-hamster ovary cells arises from differential expression of the human thyrotropin receptor and microheterogeneity of the hormone. J Clin Endocrinol Metab 1995;80:1605–1610.
Tanaka S, Yamada H, Kato EH, et al. Gestational transient hyperthyrotoxinaemia (GTH) screening for thyroid function in 23,163 pregnant women using dried blood spots. Clin Endocrinol (Oxf) 1998;49:325–329.
Kimura M, Amino N, Tamaki H, et al. Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity. Clin Endocrinol (Oxf) 1993;38:345–350.
Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992;75:1333–1337.
Tsuruta E, Tada H, Tamaki H, et al. Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 1995;80:350–355.
Hershman JM. Editorial: Role of human chorionic gonadotropin as a thyroid stimulator. J Clin Endocrinol Metab 1992;74:258–259.
Wide L, Lee JY, Rasmussen C. A change in the isoforms of human chorionic gonadotropin occurs around the 13th week of gestation. J Clin Endocrinol Metab 1994;78:1419–1423.
Yoshimura M, Pekary AK, Pang XP, Berg L, Goodwin TM, Hershman JM. Thyrotropic activity of basic isoelectric forms of human chorionic gonadotropin extracted from hydatidiform mole tissues. J Clin Endocrinol Metab 1994;78:862–866.
Rodien P, Bremont C, Raffin Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998;339:1823–1826.
Weetman AP. The immunology of pregnancy. Thyroid 1999;9:643–646.
Lazarus JH, Ludgate ME. Prevention and treatment of postpartum Graves’ disease. Bailliere’s Clin Endocrinol Metab 1997;11:549–560.
Sabhi F, Rola-Plesczcynski M, O’Connel S, Frenkel LD. Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. Am J Reprod Immunol 1995;33:381–391.
Burns DN, Nourjah P, Wright DJ, et al. Changes in immune activation markers during pregnancy and postpartum. J Reprod Immunol 1999;42:147–165.
Russell AS, Johnston C, Chew C, Maksymowych WP. Evidence for reduced Th 1 function in normal pregnancy: a hypothesis for the remission of rheumatoid arthritis. J Rheumatol 1997;24:1045–1050.
Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E. Characterisation of type 1 and type 2 cytokine production profile in physiologic and pathologic pregnancy. Clin Exp Immunol 1996;106:127–133.
Matthiesen L, Ekerfelt C, Berg G, Ernerudh J. Increased numbers of circulating interferon and interleukin4-secreting cells during normal preganancy. Am J Reprod Immunol 1998;39:362–367.
Saito S, Sakai M, Sasaki K, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and pre-eclampsia. Clin Exp Immunol 1999;117:550–555.
Lazarus JH, Ludgate M, Parkes AB. Autoimmune thyroiditis: repercussions during and after pregnancy. In: Pinchera A, Mann K, and Hostalek, U, eds. The Thyroid and Age. Merck European Thyroid Symposium, Italy, April 30-May 2, 1998. Stuttgart and New York, Schattaner, pp. 15–27.
Ekerfelt C, Matthiesen L, Berg G, Ernerudh J. Paternal leukocytes selectively increase secretion of IL-4 in peripheral blood during normal pregnancies: demonstrated by a novel one-way MLC measuring cytokine secretion. Am. J Reprod Immunol 1997; 38:320–326.
Davies TF. The thyroid immunology of the postpartum period. Thyroid 1999;9:675–684.
Elenkov IJ, Wilder RL, Bakalov VK, et al. IL-12, TNF-a, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001;86:4933–4938.
Lejeune B, Grun JP, de Nayer P, Servais G, Glinoer D. Antithyroid drugs underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension. Br J Obstet Gynecol 1993;7:669–672.
Singh A, Dantas ZN, Stone SC, Asch RH. Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril, 1995;63:277–281.
Bussen S, Stek T. Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions. Hum Reprod 1995;10:2938–2940.
Wilson R, Ling H, MacLean MA, Mooney J, Kinnane D, McKillop JH, et al. Thyroid antibody titer and avidity in patients with recurrent miscarriage. Fertil Steril 1999;71:558–561.
Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N. Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 1993;168:837–841.
Esplin MS, Branch DW, Silver R, Stagnaro-Green A. Thyroid autoantibodies are not associated with recurrent pregnancy toss. Am J Obstet Gynecol 1998;179:1583–1586.
Muller AF, Verhoeff A, Mantel MJ, Berghout A. Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization. Fertil Steril 1999;71:30–34.
Geva E, Lessing JB, Lerner-Geva L, Azem F, Yovel I, Amit A. The presence of antithyroid antibodies in euthyroid patients with unexplained infertility and tubal obstruction. Am J Reprod Immunol 1997;37:184–186.
Vaquero E, Lazzarin CD, Valensise H, Moretti C, Romanini. Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and thereapeutical approach. Am J Reprod Immunol 2000; 43:204–208.
Abramson J, Stagnaro-Green A. Thyroid antibodies and fetal loss: an evolving story. Thyroid 2001;11: 57–63.
Mestman JH. Hyperthyroidism in pregnancy. Endoc Metab Clins N Am 1998;27:127–149.
Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994;84:946–949.
Maziukiewicz US, Burrow GN. Hyperthyroidism in pregnancy, diagnosis and treatment. Thyroid 1999;9:647–652.
Hamburger JI. Diagnosis and management of Graves’ disease in pregnancy. Thyroid 1992:2:219–224.
Kung AWC, Jones BM. A change from stimulatory to blocking antibody activity in Graves’ disease during pregnancy. J Clin Endocrinol Metab 1998;83:514–518.
Zakarija M, De Forteza R, McKenzie JM, Ghandur-Mnaymneh L. Characteristics and clinical correlates of a novel thyroid-stimulating autoantibody. Autoimmunity 1994;19:31–37.
Ueta Y, Fukui H, Murakami H, Yamanoughi Y, Yamamoto R. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves’ disease in late pregnancy. Thyroid 1999;9:179–182.
Radetti G, Persani L, Moroder W, Cortelazzi D, Gentili L, Beck-Peccoz P. Transplancental passage of anti-thyroid auto-antibodies in a pregnant woman with auto-immune thyroid disease. Prenat Diagn 1999;19:468–471.
Mandel SJ, Brent GA, Larsen PR. Review of antithyroid drug use during pregnancy and report of case of aplasia cutis. Thyroid 1994;4:129–133.
Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy; results of an evidence-based symposium organized by the ETA. Eur J Endocrinol 1998;139:584–590.
Hedley AJ, Lazarus JH, McGhee SM, et al. Treatment of hyperthyroidism by radioactive iodine. Summary of a UK National Survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Phys Lond 1992;26:348–351.
Evans PMS, Webster J, Evans WD, Bevan JS, Scanlon MF. Radioiodine treatment in unsuspected pregnancy. Clin Endocrinol (Oxf) 1998;48:281–283.
Zansonico PB. Radiation dose to patients and relatives incident to 131I therapy. Thyroid 1997;7:199–204.
O’ Doherty MJ, EcElhatton PR, Thomas SHL. Treating thyrotoxicosis in pregnant or potentially pregnant women. Br Med J 1999;318:5–6.
Gorman CA. Radioiodine and pregnancy. Thyroid 1999;9:721–726.
Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 1994;170:90–95.
Momotani N, Noh JY, Ishikawa N, Ito K. Effects of anti-thyroid drugs on fetal thyroid function during the treatment of pregnant hyperthyroid women. J Clin Endocrinol Metab 1997;82:3633–3636.
Hashizume K, Ichikawa K, Nishii Y, et al. Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves’ disease. J Clin Endocrinol Metab 1992;75:6–10.
Wartofsky L. Thyrotoxic storm. In: Braverman LE Utiger RD, eds. Werner and Ingbar’s The Thyroid. 8th ed. Lippincott-Williams & Wilkins, Philadelphia 2000:679–684.
Kampmann JP, Johansen K, Hansen JM, Helweg J. Propylthiouracil in human milk: revision of dogma. Lancet 1980;1:736–737.
Momotani N, Yamashita R, Yoshimoto M, Noh J, Ishikawa N, Ito K. Recovery from fetal hypothyroidism: evidence for the safety of breast feeding while taking propylthiouracil. Clin Endocrinol (Oxf) 1989;31: 591–595.
Azizi F. Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. J Pediatr 1996;128:855–858.
Azizi F, Khoshniat M, Bahrainian M, Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000;85:3233–3238.
Fukata S, Kanji K, Sugawara M. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 1999;9:29–31.
Clementi M, Di Gianantonio ED, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy: delineation of phenotype. Am J Med Genet 1999;83:43–46.
Messer PM, Hauffa BP, Olbricht T, Benker G, Kotulla P, Reinwein D. Antithyroid drug treatment of Graves’ disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol (Copenh) 1990;123:311–316.
Eisenstern Z, Weiss M, Katz Y, Bank H. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992;151:558–559.
Shigemasa C, Mitani Y, Taniguchi S, et al. Development of postpartum spontaneously resolving transient Graves’ hyperthyroidism followed immediately by transient hypothyroidism. J Intern Med 1990; 228:23–28.
Gonzalez-Jimenez A, Fernandez-Soto ML, Escobar-Jimenez F, Glinoer D, Navarrete L. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves’ disease patients: a sequential study before, during and after pregnancy. Thyroidology 1993;5:13–20.
Hidaka Y, Tamaki H, Iwatani Y, Tada H, Mitsuda N, Amino N. Prediction of post-partum Graves’ thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy. Clin Endocrinol (Oxf) 1994;41:15–20.
Klein RZ, Haddow JE, Faixt JD, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991;35: 41–46.
Glinoer D, Fernandez Soto M, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991;73:421–427.
Allen WC, Haddow JE, Palomaki GE, et al. Maternal thyroid efficiency and pregnancy complications: implications for populaiton screening. J Med Screen 2000;7:127–130.
Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 1997;82:2862–2866.
Tamaki H, Amino N, Takeoka K, Mitsuda N, Miyai K, Tanizawa O. Thyroxine requirement during pregnancy for replacement therapy of hypothyroidism. Obstet Gynecol 1990;76:230–233.
Man EB, Brown JF, Serunian SA. Maternal hypothyroxinemia: psycho-neurological deficits of progeny. Ann Clin Lab Sci 1991;21:227–239.
Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999;50: 149–155.
Pop VJ, de Vries E, van Baar AL, et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab 1995;80:3561–3566.
Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549–555.
Amino N, Tada H, Hidaka Y, Crapo LM, Stagnaro-Green A. Therapeutic controversy. Screening for postpartum thyroiditis. J Clin Endocrinol Metab 1999;84:1813–1821.
Lazarus JH, Parkes AB, John R. Kooistra A, Rees A. Early gestational thyroid function in anti-TPO positive and negative women. 25th Annual Meeting of the European Thyroid Association, Athens 30 May-3 June. J Endocrinol Invest 1998;21(abstr 104):52.
Hay I. Nodular thyroid disease diagnosed during pregnancy: how and when to treat. Thyroid 1999; 9:667–670.
Herzon FS, Morris DM, Segal MN, Rauch G, Parnell T. Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg 1994;20:1191–1193.
Smallridge RC. Postpartum thyroid diseases through the ages: A historical view. Thyroid 1999; 9:671–673.
Choe W, McDougall IR. Thyroid cancer in pregnant women: diagnostic and therapeutic management. Thyroid 1994;4:433–435.
Lin JD, Wang HS, Weng HF, Kao PF. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas. J Endocrinol Invest 1998;21:662–667.
Roberton HEW. Lassitude, coldness, and hair changes following pregnancy, and their response to treatment with thyroid extract. Br Med J 1948;2:93–94.
Amino N, Miyai KJ, Onishi T, Hashimoto T, Arai K. Transient hypothyroidism after delivery in autoimmune thyroiditis. J Clin Endocrinol Metab 1976;42:296–301.
Ginsberg J, Walfish PG. Postpartum transient thyrotoxicosis with painless thyroiditis. Lancet 1977;1: 1125–1128.
Stagnaro-Green A. Postpartum thyroiditis: Prevalence, etiology and clinical implications. Thyroid Today 1993;16:1–11.
Lazarus JH, Premawardhana LDK, Parkes AB. Postpartum thyroiditis. In: Weetman AP, ed. Immunology and Medicine Series. Endocrine Autoimmunity and Associated Conditions. Kluwer, London 1998;27:83–97.
Smallridge RC. Postpartum thyroid disease: a model of immunologic dysfunction. Clin Applied Immunol Rev 2000;1:89–103.
Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age; recent insights and cosequences for antenatal and postnatal care. Endocr Rev 2001;22:605–630
Hall R. Pregnancy and autoimmune endocrine disease. In: Baillieres Clin Endocrinol Metab1995;9: 137–155.
Kuijpens JL, De Hann-Meulman M, Vader HL, Pop VJ, Wiersinga WM, Drexhage HA. Cell-mediated immunity and postpartum thyroid dysfunction: a possibility for the prediction of disease? J Clin Endocrinol Metab 1998;83:1959–1966.
Kuijpens JL, Pop VJ, Vader HL, Drexhage HA, Wiersinga WM. Prediction of postpartum thyroid dysfunction: can it be improved? Eur J Endocrinol 1998;139: 36–43.
Lazarus JH, Hall R, Othman S, Parkes CJ, Richards McCulloch B, Harris B. The clinical spectrum of postpartum thyroid disease. Q J Med 1996;89:429–435.
Harris B, Fung H, Johns S, et al. Transient post-partum thyroid dysfunction and postnatal depression. J Affect Disord 1989;17:243–249.
Pop VJ, De Rooy HA, Vader HL, et al. Postpartum thyroid dysfunction and depression in an unselected population. N Engl J Med 1991;324:1815–1816.
Harris B, Othman S, Davies J, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. Br Med J 1992;305:152–156.
Harris B, Oretti R, Lazarus J, et al. Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody positive women. Br J Psychiatr 2002;180:327–330.
John R, Othman S, Parkes AB, Lazarus JH, Hall R. Interference in thyroid function tests in postpartum thyroiditis. Clin Chem 1991;37:1397–1400.
Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999;9:705–713.
Adams H, Jones MC, Othman S, et al. The sonographic appearances in postpartum thyroiditis. Clin Radiol 1992;45:311–318.
Creagh FM, Parkes AB, Lee A, et al. The iodide perchlorate discharge test in women with previous post-partum thyroiditis: relationship to sonographic appearance and thyroid function. Clin Endocrinol (Oxf) 1994;40:765–768.
Othman S, Phillips DIW, Lazarus JH, Parkes AB, Richards C, Hall R. Iodine metabolism in postpartum thyroiditis. Thyroid 1992;2:107–111
Parkes AB, Black EG, Adams H, et al. Serum thyroglobulin—an early indicator of autoimmune postpartum thyroiditis. Clin Endocrinol (Oxf) 1994;41:9–14
Nohr S, Laurberg P, Jorgensen A, Pedersen KM. Postpartum thyroid dysfunction in pregnant TPO-Ab positive women living in an area with mild iodine deficiency—is iodine supplementation safe? J Endocrinol Invest 1999;22(abstr):96,192.
Parkes AB, Othman S, Hall R, Rhys John, Lazarus JH. The role of complement in the pathogenesis of postpartum thyroiditis: relationship between complement activation and disease presentation and progression. Eur J Endocrinol 1995;133:210–215
Stagnaro-Green A, Roman H, Cobin RH, El-Harazy E, Wallenstein S, Davies TF. Prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab 1992;74:645–653.
Ahmad L, Kita M, Unger P, Davies TF. Pregnancy suppresses the development of mouse thyroiditis by enhancing TH2 responses. Proceedings of 71st Annual Meeting of the American Thyroid Association, Portland, OR, Sept. 6–20, 1998 abstr.
Premawardhana LD, Parkes AB, Ammari F, et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000;85:71–75.
Amino N, Miyai K, Kuro P, Tanizawa O, Azukizawa M, Takai S, et al. Transient postpartum hypothyroidism: fourteen cases with autoimmune thyroiditis. Ann Intern Med 1977; 87:155–159.
Lazarus JH, Ammari F, Oretti R, Parkes AB, Richards CJ, Harris B. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997;47:305–308.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lazarus, J.H. (2003). Thyroid Dysfunction During Pregnancy and After Delivery. In: Braverman, L.E. (eds) Diseases of the Thyroid. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-352-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-59259-352-1_14
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-405-0
Online ISBN: 978-1-59259-352-1
eBook Packages: Springer Book Archive